News
The Global Nucleic Acid Isolation and Purification Market is segmented into drug discovery & development, precision medicine, diagnostics, agriculture and animal research, and other, based on ...
Merck & Co. will pay as much as $2 billion for the rights to Jiangsu Hengrui Pharmaceuticals Co.’s experimental heart drug, the US drugmaker’s second recent foray into China for a novel medicine.
Merck & Co. is handing over $200 million to China’s Hengrui Pharma for a phase 2-stage lipoprotein(a) (Lp(a)) inhibitor. In return for the ex-China rights to the drug, dubbed HRS-5346, Merck has ...
It is hard to get excited after looking at Merck's (NYSE:MRK) recent performance, when its stock has declined 7.2% over the past three months. But if you pay close attention, you might gather that ...
Sigma-Aldrich Corporation is a life science and high technology company. The Company develops, manufactures, purchases and distributes a range of chemicals, biochemicals and equipment globally.
Merck was one of the pioneers of the cholesterol-lowering statins that launched in the 1980s and 1990s and changed medical practice. But it hasn’t been as successful with cholesterol medicines since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results